Truist Financial CEO Purchases Company Stock via SEC Filing
1 report, 1 independent
Updated Sep 21
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Michael P. Lyons, President & CEO of Truist Financial Corporation, executed a direct purchase of 21,000 shares of common stock on September 17, 2026. The purchase was reported via an SEC Form 4 filing on September 21, 2026. The shares were acquired at a weighted-average price of $48.36, which was below the market close price of $48.45 on the day of the transaction.
From fool.com
Why it matters
The purchase establishes a new direct common stock holding of 21,000 shares for the President & CEO. The investment signals a discretionary increase in direct exposure to the regional bank.
From fool.com
Who's involved
- Truist FinancialCompany subject of the insider transaction
Keep exploring
The entities involved
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Simmons Bank increased its stake in Wells Fargo shares, while Truist Financial boosted its price objective on the company.
- Treace Medical Concepts disclosed a purchase in an SEC filing, and Truist Financial increased its target price for the company.
- Arrow Financial Corporation announced an acquisition agreement to merge insurance operations and sold major insurance holdings.
- Denkapparat Operations GmbH acquired a new stake in Popular, Inc., while Benchmark and Truist Financial issued 'buy' ratings and increased target prices.